Intranasal corticosteroids are used to control symptoms associated with sneezing, rhinorrhea, itching and nasal congestion.

* Intranasal tumors ( e. g. Nasopharyngeal carcinoma or nasopharyngeal angiofibroma )

They are chiefly responsible for releasing hormones in response to stress through the synthesis of corticosteroids such as cortisol and catecholamines such as epinephrine ( adrenaline ) and norepinephrine.

Paradoxically it has been demonstrated that oral administration of corticosteroids in this situation may lead to more recurrent attacks than in non-treated patients ( though oral steroids are generally prescribed after the intravenous course, to wean the patient off the medication ).

It can be difficult to determine whether disease manifestations are directly caused by the rheumatoid process itself, or from side effects of the medications commonly used to treat it – for example, lung fibrosis from methotrexate or osteoporosis from corticosteroids.

There are no randomized trials of corticosteroids for SJS, and it can be managed successfully without them.

Several anti-itch medications are commercially available, including those taken orally, such as Benadryl, or topically applied antihistamines and, for more severe cases, corticosteroids, such as hydrocortisone and triamcinolone.

Leukotriene antagonists are less effective than corticosteroids and thus less preferred.

* Medical disorders that lead to fluid retention or are associated with inflammation such as: inflammatory arthritis, Colles ' fracture, amyloidosis, hypothyroidism, diabetes mellitus, acromegaly, and use of corticosteroids and estrogens.

Otherwise, the main recommended treatments are local corticosteroid injection, splinting ( immobilizing braces ), oral corticosteroids and ultrasound treatment.

These three treatments are laser surgery, injection of corticosteroids or Anti-VEGF into the eye, and vitrectomy.

The corticosteroids are synthesized from cholesterol within the adrenal cortex.

In general, corticosteroids are grouped into four classes, based on chemical structure.

Topical corticosteroids are divided in potency classes I to IV,

Its principal effects are increased production and release of corticosteroids.

Prolonged use of corticosteroids has significant side-effects ; as a result, they are, in general, not used for long-term treatment.

biologic treatments such as Infliximab ( trade name Remicade ), adalimumab ( trade name Humira ) and Golimumab ( trade name Simponi ) are commonly used to treat patients with Ulcerative Colitis who are no longer responding to corticosteroids.

Usually these medications are only used after other options have been exasperated ( i. e. patient has received high dose corticosteroids, immunomodulators such as Azathioprine and Mesalazine ) but in certain cases, patients may skip these steps and start biologic treatments under doctor orders.

Some medications are commonly associated with pancreatitis, most commonly corticosteroids such as prednisolone, but also including the HIV drugs didanosine and pentamidine, diuretics, the anticonvulsant valproic acid, the chemotherapeutic agents L-asparaginase and azathioprine, estrogen by way of increased blood triglycerides, cholesterol-lowering statins and the antihyperglycemic agent sitagliptin.

Often, owners seek expert help only when the disease is in its advanced stages ( nervous phase ) due to the nonspecific earlier signs and prescription of anti-inflammatory drugs ( which are usually corticosteroids ) undermine the immune system of the animal, allow the proliferation of the virus, and the autoimmune reaction increases as a means of containment of infected cells.

Intravenous corticosteroids, usually hydrocortisone or dexamethasone, are not recommended for routine use but may be useful if there is a risk of airway obstruction, severe thrombocytopenia, or hemolytic anemia.

* Intralesional corticosteroids are first-line therapy for most keloids.

A systematic review found that up to 70 % of patients respond to intralesional corticosteroid injection with flattening of keloids, although the recurrence rate is high in some studies ( up to 50 % at five years ) While corticosteroids are one of the more common treatments, injections into and in close proximity to keloid tissue can be highly painful and can produce undesirable results in female patients.

Topical corticosteroids frequently fail to enter the skin deeply enough to affect the hair bulbs, which are the treatment target.

Oral corticosteroids decrease the hair loss, but only for the period during which they are taken, and these drugs have serious adverse side effects.

This treatment shows promise as being superior to corticosteroids when treating IHs, but there are no controlled trials to date that prove this.

Inhaled corticosteroids are the preferred treatment for children, however these drugs can reduce the growth rate.

In some resistant cases, corticosteroids can be used but are not preferred due to the high frequency of relapse when corticosteroid therapy is discontinued.

Death is common in the first week and overall mortality is about 70 %, but increasing evidence points to favorable outcomes after aggressive treatment with corticosteroids, immunoglobulins, cyclophosphamide, and plasma exchange.

* any drug treatment that affects insulin sensitivity ( e. g. corticosteroids )

Therefore, systemic intravenous treatment with corticosteroids, which may quicken the healing of the optic nerve, is often recommended.

A systematic review identified 20 randomised controlled trials and included 12, 303 participants, compared patients who received corticosteroids with patients who received no treatment.

Acute treatment uses medications to treat any infection ( normally antibiotics ) and to reduce inflammation ( normally aminosalicylate anti-inflammatory drugs and corticosteroids ).

* The topical administration of medications into the rectum, such as corticosteroids and mesalazine used in the treatment of inflammatory bowel disease.

Iatrogenic Cushing's syndrome ( caused by treatment with corticosteroids ) is the most common form of Cushing's syndrome.

Combination treatment with pulsed dye laser plus intralesional therapy with corticosteroids and / or fluorouracil may be superior to either approach alone.

Most treatment has relied so far on trying to counteract the released chemicals with anti-histamines, corticosteroids or Salbutamol.

At present, the best form of treatment for dust mite allergies is avoidance of dust mites and their allergens combined with medication such as anti-histamines, corticosteroids or Salbutamol.

There may be a role for the use of corticosteroids ( for tuberculous pleurisy ), tacrolimus ( Prograf ) and methotrexate ( Trexall, Rheumatrex ) in the treatment of pleurisy.

Orally administered corticosteroids are frequently used in treatment of the infection, despite clinical trials of this treatment being unconvincing.

* Topical steroid: Chronic treatment with topical corticosteroids may lead to permanent atrophy and telangiectasia of the skin.

* use of inhaled corticosteroids for asthma treatment

High-dose corticosteroids such as prednisone are a standard treatment ; however this immuno-suppressive treatment often leads to deadly infections.

Adrenaline ( epinephrine ) remains the mainstay of treatment, with corticosteroids and antihistamines providing limited benefit in the acute situation.

In severe IRIS cases, treatment with systemic corticosteroids has been utilized.